These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Bitolterol mesylate aerosol in adults with steroid-dependent asthma: a comparison with isoproterenol hydrochloride aerosol. Nathan RA, Bodman SF, Storms WW, Mingo TS. Ann Allergy; 1986 Jun; 56(6):494-9. PubMed ID: 3717716 [Abstract] [Full Text] [Related]
3. Clinical study on carbuterol (SKF 40383), a new selective bronchodilator agent aerosol: double blind comparison with isoproterenol aerosol. Saleeby PR, Ziskind MM. Curr Ther Res Clin Exp; 1975 Mar; 17(3):225-33. PubMed ID: 805017 [No Abstract] [Full Text] [Related]
4. Long-term study comparing fenoterol and isoproterenol inhalation in asthmatic patients. Brandon ML. Ann Allergy; 1978 Feb; 40(2):86-93. PubMed ID: 343660 [Abstract] [Full Text] [Related]
5. Bitolterol mesylate (WIN 32784) aerosol. A new long-acting bronchodilator with reduced chronotropic effects. Kass I, Mingo TS. Chest; 1980 Aug; 78(2):283-7. PubMed ID: 6995040 [Abstract] [Full Text] [Related]
6. Spirometric comparison of carbuterol and isoproterenol aerosol therapy in bronchial asthma. A double blind, matched-pair study of 28 adults and a double blind crossover study of 18 children. Rhoades RB, Leifer KN, Bloom FL, Wittig HJ. Am Rev Respir Dis; 1976 Jul; 114(1):79-86. PubMed ID: 7174 [Abstract] [Full Text] [Related]
7. Outpatient management of asthma with regular nebulized beta agonists: comparison of bitolterol mesylate and isoproterenol. Kemp JP, Orgel HA, Grossman J, Reed CE, Tinkelman DG, Webb DR, Ziment I. Ann Allergy; 1987 Jul; 59(1):17-20. PubMed ID: 3300436 [Abstract] [Full Text] [Related]
13. Bitolterol. A preliminary review of its pharmacological properties and therapeutic efficacy in reversible obstructive airways disease. Friedel HA, Brogden RN. Drugs; 1988 Jan; 35(1):22-41. PubMed ID: 3278878 [Abstract] [Full Text] [Related]
14. A double-blind parallel study of acetylcysteine-isoproterenol and saline-isoproterenol in patients with chronic obstructive lung disease. Cato A, Goldstein I, Millman M. J Int Med Res; 1977 Jan; 5(3):175-83. PubMed ID: 330289 [Abstract] [Full Text] [Related]
15. The one best test for evaluating the effects of bronchodilator therapy. Light RW, Conrad SA, George RB. Chest; 1977 Oct; 72(4):512-6. PubMed ID: 908220 [No Abstract] [Full Text] [Related]
16. In chronic obstructive pulmonary disease, a combination of ipratropium and albuterol is more effective than either agent alone. An 85-day multicenter trial. COMBIVENT Inhalation Aerosol Study Group. Chest; 1994 May; 105(5):1411-9. PubMed ID: 8181328 [Abstract] [Full Text] [Related]
17. Multicenter study of bitolterol and isoproterenol nebulizer solutions in nonsteroid-using patients. Pinnas JL, Bernstein IL, Bronsky EE, Bush RK, Chervinsky P, Condemi JJ, Dockhorn RJ, Nathan RA, Repsher LH, Bhatt BD. J Allergy Clin Immunol; 1987 May; 79(5):768-75. PubMed ID: 3571768 [Abstract] [Full Text] [Related]
19. Long-term evaluation of a new aerosol bronchodilator, carbuterol, and comparison with isoproterenol. Drachler DH, Bower JS, Miller DA, Rotman HH. J Clin Pharmacol; 1977 May; 17(11-12):734-9. PubMed ID: 336653 [Abstract] [Full Text] [Related]